Sorbonne Université, INSERM, UMRS1158 Neurophysiologie Respiratoire Expérimentale et Clinique, Paris, France
AP-HP, Groupe Hospitalier Universitaire APHP-Sorbonne Université, hôpital Pitié-Salpêtrière, Service de Pneumologie (Département R3S), Paris, France.
Eur Respir J. 2024 Sep 12;64(3). doi: 10.1183/13993003.00485-2024. Print 2024 Sep.
Dyspnoea persisting despite treatments of underlying causes requires symptomatic approaches. Medical hypnosis could provide relief without the untoward effects of pharmacological approaches. We addressed this question through experimentally induced dyspnoea in healthy humans (inspiratory threshold loading (excessive inspiratory effort) and carbon dioxide stimulation (air hunger)).
20 volunteers (10 women, aged 21-40 years) were studied on four separate days. The order of the visits was randomised in two steps: firstly, the "inspiratory threshold loading first" "carbon dioxide first" group (n=10 in each group); secondly, the "medical hypnosis first" "visual distraction first" subgroup (n=5 in each subgroup). Each visit comprised three 5-min periods (reference, intervention, washout) during which participants used visual analogue scales (VAS) to rate the sensory and affective dimensions of dyspnoea, and after which they completed the Multidimensional Dyspnea Profile.
Medical hypnosis reduced both dimensions of dyspnoea significantly more than visual distraction (inspiratory threshold loading: sensory reduction after 5 min 34% of full VAS 8% (p=0.0042), affective reduction 17.6% 2.4% (p=0.044); carbon dioxide: sensory reduction after 5 min 36.9% 3% (p=0.0015), affective reduction 29.1% 8.7% (p=0.0023)). The Multidimensional Dyspnea Profile showed more marked sensory effects during inspiratory threshold loading and more marked affective effects during carbon dioxide stimulation.
Medical hypnosis was more effective than visual distraction at attenuating the sensory and affective dimensions of experimentally induced dyspnoea. This provides a strong rationale for clinical studies of hypnosis in persistent dyspnoea patients.
尽管针对潜在病因进行了治疗,但仍持续存在的呼吸困难需要采取对症治疗方法。医学催眠可以提供缓解,而不会产生药理学方法的不良作用。我们通过在健康人群中诱发呼吸困难(吸气阈负荷(过度吸气努力)和二氧化碳刺激(空气饥饿))来解决这个问题。
在四个不同的日子里,研究了 20 名志愿者(10 名女性,年龄 21-40 岁)。访问的顺序以两步随机化方式进行:首先,“吸气阈负荷首先”“二氧化碳首先”组(每组 10 人);其次,“医学催眠首先”“视觉分散首先”亚组(每组 5 人)。每次访问包括三个 5 分钟的时间段(参考、干预、冲洗),在此期间参与者使用视觉模拟量表(VAS)来评定呼吸困难的感觉和情感维度,之后他们完成多维呼吸困难量表。
与视觉分散相比,医学催眠显著降低了呼吸困难的两个维度(吸气阈负荷:5 分钟后感觉降低 34%,全 VAS 的 8%(p=0.0042),情感降低 17.6%,2.4%(p=0.044);二氧化碳:5 分钟后感觉降低 36.9%,全 VAS 的 3%(p=0.0015),情感降低 29.1%,8.7%(p=0.0023))。多维呼吸困难量表显示在吸气阈负荷时感觉效果更明显,在二氧化碳刺激时情感效果更明显。
医学催眠比视觉分散更有效地减轻实验性诱导的呼吸困难的感觉和情感维度。这为持续性呼吸困难患者的催眠临床研究提供了有力的依据。